This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Astra Zeneca U.k. Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Joe Francica: Innovator in Antibody Development
Introduction
Joe Francica is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target the spike protein of SARS-CoV-2. His work is crucial in the ongoing fight against COVID-19.
Latest Patents
Joe Francica holds a patent for "Antibodies That Bind the Spike Protein of SARS-CoV-2." This innovation is vital for therapeutic and diagnostic applications related to the virus, showcasing his expertise in antibody engineering.
Career Highlights
Currently, Joe is employed at AstraZeneca UK Limited, where he continues to work on groundbreaking research in the pharmaceutical industry. His role at AstraZeneca allows him to collaborate with leading scientists and contribute to the development of life-saving treatments.
Collaborations
Joe has worked alongside talented colleagues, including Saravan Rajan and Gilad Kaplan. Their combined efforts in research and development have led to advancements in antibody therapies.
Conclusion
Joe Francica's contributions to antibody development, particularly in relation to SARS-CoV-2, highlight his importance in the field of biotechnology. His work at AstraZeneca and his collaborations with other experts further emphasize his commitment to innovation and public health.